Dai et al. reported that the myeloid cell leukemia-1 (MCL1) is negatively correlated with that of NKs and that the combined action of MCL1 inhibitors and NKs can significantly exhaust primary AML cells and cell lines. This evidence concerns the gene MCL1 and acute myeloid leukemia.